TKNO
Alpha Teknova, Inc.
Drug Manufacturers - Specialty & Generic · Healthcare · United States
7.36
close · 2026-10-30
value
9
cheaper than peers9
quality
42
stronger fundamentals42
ranked against
Drug Manufacturers - Specialty & Generic
value
quality
41 peerswide variation
Value inputs
| measure | company | vs peers |
| earnings yield, 1 year ago | -7.7% | 35 |
| cash flow yield, latest year | -2.2% | 30 |
| earnings yield, latest year | -4.3% | 30 |
| earnings yield, 2 years ago | -15.8% | 29 |
| cash flow yield, 1 year ago | -3.0% | 28 |
| price to book | 6.31× | 27 |
| cash flow yield, 2 years ago | -5.9% | 26 |
| cash flow yield, 3 years ago | -12.2% | 23 |
| earnings yield, 3 years ago | -23.0% | 19 |
| price to sales | 10.86× | 7 |
10 of 12 measures available
Quality inputs
| measure | company | vs peers |
| debt to equity | 42.9% | 73 |
| revenue growth | 13.1% | 66 |
| return on equity | -23.9% | 34 |
| operating margin | -38.8% | 14 |
4 of 4 measures available
Facts
| market cap | $454M |
| free cash flow | -$2.4M |
| employees | 158 |
| first trade | 2021-06-25 |
| next earnings | 2026-11-04 |
| fundamentals updated | 2026-08-05 |
Annual history
| measure | 2025 | 2024 | 2023 | 2022 |
| diluted eps | -0.32 | -0.57 | -1.16 | -1.69 |
| free cash flow | -$9.8M | -$13.5M | -$26.7M | -$55.5M |
| net income | -$17.3M | -$26.7M | -$36.8M | -$47.5M |
| revenue | $40.5M | $37.7M | $36.7M | $41.4M |
| unusual items | $485,000 | $0 | -$5.2M | -$20.8M |